Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
Authors
Keywords
-
Journal
MOLECULAR PHARMACOLOGY
Volume 97, Issue 1, Pages 9-22
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2019-11-10
DOI
10.1124/mol.119.117937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel pyrrolo[3,2-d]pyrimidine compounds target mitochondrial and cytosolic one-carbon metabolism with broad-spectrum antitumor efficacy
- (2019) Aamod S. Dekhne et al. MOLECULAR CANCER THERAPEUTICS
- Fluorine-Substituted Pyrrolo[2,3-d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis
- (2018) Manasa Ravindra et al. JOURNAL OF MEDICINAL CHEMISTRY
- Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs
- (2018) Denise R. Minton et al. MOLECULAR CELL
- Mitochondrial translation requires folate-dependent tRNA methylation
- (2018) Raphael J. Morscher et al. NATURE
- mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
- (2018) Shun-Qing Liang et al. ONCOGENE
- Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells
- (2018) Yuxiang Zheng et al. CELL
- Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma
- (2017) Gregory S. Ducker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serine and Functional Metabolites in Cancer
- (2017) Alice C. Newman et al. TRENDS IN CELL BIOLOGY
- Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
- (2017) Ming Wu et al. OncoTargets and Therapy
- The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels
- (2017) Gerta Hoxhaj et al. Cell Reports
- Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway
- (2016) Gregory S. Ducker et al. Cell Metabolism
- Tumour-specific proline vulnerability uncovered by differential ribosome codon reading
- (2016) Fabricio Loayza-Puch et al. NATURE
- Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker
- (2016) Lahong Zhang et al. ONCOLOGY REPORTS
- KRAS-related proteins in pancreatic cancer
- (2016) Karen M. Mann et al. PHARMACOLOGY & THERAPEUTICS
- Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
- (2016) Chuanzhao Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serine one-carbon catabolism with formate overflow
- (2016) J. Meiser et al. Science Advances
- 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors
- (2015) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
- (2015) Dohoon Kim et al. NATURE
- Mammalian Mitochondrial and Cytosolic Folylpolyglutamate Synthetase Maintain the Subcellular Compartmentalization of Folates
- (2014) Scott A. Lawrence et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer
- (2014) Hui Jun Lim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
- (2014) Roland Nilsson et al. Nature Communications
- Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia
- (2014) J. Ye et al. Cancer Discovery
- Discovery of 5-Substituted Pyrrolo[2,3-d]pyrimidine Antifolates as Dual-Acting Inhibitors of Glycinamide Ribonucleotide Formyltransferase and 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase in De Novo Purine Nucleotide Biosynthesis: Implications of Inhibiting 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase to AMPK Activation and Antitumor Activity
- (2013) Shermaine Mitchell-Ryan et al. JOURNAL OF MEDICINAL CHEMISTRY
- The human proton-coupled folate transporter
- (2012) Sita Kugel Desmoulin et al. CANCER BIOLOGY & THERAPY
- Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation
- (2012) M. Jain et al. SCIENCE
- Oxidative Stress and Antioxidant Defense
- (2012) Esra Birben et al. World Allergy Organization Journal
- Mechanisms of Membrane Transport of Folates into Cells and Across Epithelia
- (2011) Rongbao Zhao et al. Annual Review of Nutrition
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
- (2011) Brian Magnuson et al. BIOCHEMICAL JOURNAL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tetrahydrofolate Recognition by the Mitochondrial Folate Transporter
- (2011) Scott A. Lawrence et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis, Biological, and Antitumor Activity of a Highly Potent 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitor with Proton-Coupled Folate Transporter and Folate Receptor Selectivity over the Reduced Folate Carrier That Inhibits β-Glycinamide Ribonucleotide Formyltransferase
- (2011) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors Based on Selective Uptake by the Proton-Coupled Folate Transporter
- (2011) S. Kugel Desmoulin et al. MOLECULAR PHARMACOLOGY
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Compartmentalization of Mammalian Folate-Mediated One-Carbon Metabolism
- (2010) Anne S. Tibbetts et al. Annual Review of Nutrition
- Biochemical and biophysical characterization of succinate: Quinone reductase from Thermus thermophilus
- (2010) Olga Kolaj-Robin et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Pemetrexed Indirectly Activates the Metabolic Kinase AMPK in Human Carcinomas
- (2010) S. B. Rothbart et al. CANCER RESEARCH
- Therapeutics by Cytotoxic Metabolite Accumulation: Pemetrexed Causes ZMP Accumulation, AMPK Activation, and Mammalian Target of Rapamycin Inhibition
- (2009) Alexandra C. Racanelli et al. CANCER RESEARCH
- Synthesis and Biological Activity of a Novel Series of 6-Substituted Thieno[2,3-d]pyrimidine Antifolate Inhibitors of Purine Biosynthesis with Selectivity for High Affinity Folate Receptors over the Reduced Folate Carrier and Proton-Coupled Folate Transporter for Cellular Entry†
- (2009) Yijun Deng et al. JOURNAL OF MEDICINAL CHEMISTRY
- N-linked glycosylation and its impact on the electrophoretic mobility and function of the human proton-coupled folate transporter (HsPCFT)
- (2008) Ersin Selcuk Unal et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- A Role for the Proton-coupled Folate Transporter (PCFT-SLC46A1) in Folate Receptor-mediated Endocytosis
- (2008) Rongbao Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis and Discovery of High Affinity Folate Receptor-Specific Glycinamide Ribonucleotide Formyltransferase Inhibitors with Antitumor Activity
- (2008) Yijun Deng et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started